Measure of Acceptance of chRonic Visible sKin conditionS

Recruiting

• Conditions: Social Segregation; Acceptance of Visible Chronic Dermatological Disease; Psychological Well-Being; Disease Acceptance
• Interventions: Behavioral: Questionnaire

• Registration Number: NCT06103903
• Lead Sponsor: University Hospital, Tours

Brief Summary

The objective of this protocol is to validate 4 scales for evaluating the acceptance of visible chronic dermatological diseases (port wine stains, alopecia areata, vitiligo, hyperpigmentation...) with a large number of patients (children, adolescents, adults) and their parents (depending on the composition of the family cluster), in a multicentric manner (for territorial representativeness).

Detailed Description

The objective of this protocol is to validate 4 scales for evaluating the acceptance of visible chronic dermatological diseases (port wine stains, alopecia areata, vitiligo, hyperpigmentation...) with a large number of patients (children, adolescents, adults) and their parents (depending on the composition of the family cluster), in a multicentric manner (for territorial representativeness).

The investigator will screen the patients and give them a link to complete the questionnaire (according to the age), that includes a pre-scale of acceptation of 50-55 items.

Study Timeline

• Study Start: 2022-01-01
• Status Verified: 2023-10
• Study First Submitted: 2023-10-18
• Study First Submitted QC: 2023-10-24
• Last Update Submitted: 2023-10-24
• Study First Posted: 2023-10-27
• Last Update Posted: 2023-10-27
• Primary Completion: 2025-12-31
• Study Completion: 2025-12-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

1. Targeted pathologies:

   • Flat angioma
   • Primary hypopigmentation and early vitiligo
   • Primary hyperpigmentation
   • Refractory alopecia areata or congenital alopecia

2. Persons concerned:

   • Children (≥ 6 years old) suffering from one of the aforementioned pathologies
   • Adults suffering from one of the above-mentioned pathologies
   • Parents of children suffering from one of the aforementioned pathologies
   • Parents of young adult patients if they live under the same roof

3. Oral agreement for each person (major/minor) and, where applicable, one of the holders of parental authority (minor)

Exclusion Criteria

1. Secondary "marks" (post-inflammatory, post-medication, post-traumatic, etc.)
2. Major psychiatric disorders

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Adolescents aged 14-17 years	Questionnaire	Adolescents aged 14-17 years years with a chronic skin visible disease
Adult patients	Questionnaire	Adult patients aged 18 years and more with a chronic skin visible disease
Parents of children aged 6 years and more	Questionnaire	Parents of children aged 6 years and more with a chronic skin visible disease
Children aged 6-13 years	Questionnaire	Children aged 6-13 years with a chronic skin visible disease

Primary Outcome Measures

Name	Time	Method
Questionnaire analysis	Up to 4 weeks	Analysis of responses to the 4 questionnaires (scales) evaluating the acceptance of chronic dermatological diseases visible in children, adolescents, adults and parents, respectively.

Trial Locations

Locations (1)

University Hospital TOURS; 🇫🇷 Tours, France